How Do You Distinguish Inflammatory Bowel Disease From Irritable Bowel Syndrome?

Answer in brief: IBD causes objective intestinal inflammation; IBS does not. History identifies risk and alarm features, but biomarkers—especially fecal calprotectin—can help separate inflammatory from functional disease in appropriate patients. Persistent bleeding, weight loss, anemia, nocturnal symptoms, fever, perianal disease, elevated inflammatory markers or a strong family history lowers the threshold for endoscopy and imaging.

Symptoms overlap more than textbooks suggest

Both IBD and IBS can cause abdominal pain, diarrhea, urgency and bloating. Stool frequency alone is not diagnostic. The distinction comes from inflammatory evidence, disease trajectory and alarm features rather than from one symptom.

Look for clues that IBS does not explain well

Rectal bleeding, progressive weight loss, iron-deficiency anemia, fever, nocturnal diarrhea, growth failure, fistula/perianal disease and objective inflammatory abnormalities should trigger investigation for organic disease. Recent infection, medication exposure and celiac disease also enter the differential.

Fecal calprotectin is useful when pretest probability is intermediate

A low fecal calprotectin makes active colonic IBD less likely in many symptomatic patients and can reduce unnecessary colonoscopy. Elevated results are not specific to IBD and may occur with infection, NSAID use, neoplasia and other inflammatory conditions.

Endoscopy establishes more than inflammation

When IBD is suspected, colonoscopy with ileal intubation and biopsies helps define distribution, severity and histology. Cross-sectional imaging may be needed for suspected small-bowel Crohn’s disease even when colonoscopy is unrevealing.

IBS can coexist with IBD

A patient with established IBD can have persistent IBS-like symptoms after inflammation is controlled. Escalating immunosuppression without objective evidence of activity can therefore cause harm.

What trainees should remember

IBS is a positive clinical diagnosis, but only after the probability of inflammatory disease is appropriately assessed. Use alarm features and objective inflammation testing rather than symptoms alone.

Frequently asked questions

Does a normal CRP rule out IBD?

No. Some patients with active IBD have normal CRP, especially with limited disease.

Can IBS cause an elevated fecal calprotectin?

IBS itself should not cause substantial intestinal inflammatory-marker elevation, but modest elevations can have other explanations and need context.

References and further reading

1. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children, 7th ed. CAPstone Academic Publishers; 2013.

3. Lichtenstein GR, et al. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2025.